Troy’s odyssey

Executive Summary

Former FDA Chief Counsel Dan Troy and Special Assistant to the Chief Counsel Coleen Klasmeier will join Sidley Austin Brown & Wood this month, the law firm announces Jan. 6. Troy will provide "strategic counsel on FDA-related matters" and practice administrative and constitutional law with a focus on the pharma, biotech and medical device industries; he announced his departure from FDA in November (1"The Tan Sheet" Nov. 22, 2004, p. 10). Klasmeier is joining the firm's life sciences practice with a focus on the pharma, medical device and food industries...